CXCR3 and neoplasm: We found that PTPN2‐deficient HER‐2 CAR T cells expressed higher cell surface levels of CXCR3 in vitro prior to adoptive transfer (Fig 6C) as well as in vivo after CAR T cells had infiltrated tumours (Fig EV3C).